• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用半合成α-突触核蛋白研究帕金森病中 O-GlcNAc 修饰的作用。

Investigating the Effects of O-GlcNAc Modifications in Parkinson's Disease Using Semisynthetic α-Synuclein.

机构信息

Department of Chemistry, University of Southern California, Los Angeles, CA, USA.

Department of Biological Sciences, University of Southern California, Los Angeles, CA, USA.

出版信息

Methods Mol Biol. 2020;2133:313-326. doi: 10.1007/978-1-0716-0434-2_15.

DOI:10.1007/978-1-0716-0434-2_15
PMID:32144674
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7143810/
Abstract

α-Synuclein is a small aggregation-prone protein associated with Parkinson's disease (PD). The protein's biochemical and biophysical properties can be heavily influenced by various types of posttranslational modification (PTMs) such as phosphorylation, ubiquitination, and glycosylation. To understand the site-specific effects of various PTMs have on the protein and its aggregation, obtaining a homogeneous sample of the protein of interest with the specific modification of interest is key. Expressed protein ligation (EPL) has emerged as robust tool for building synthetic proteins bearing site-specific modifications. Here, we outline our approach for building α-synuclein with site specific O-GlcNAc modifications, an intracellular subtype of glycosylation that has been linked to the inhibition of protein aggregation. More specifically, we provide specific protocols for the synthesis of α-synuclein bearing an O-GlcNAc modification at threonine 72, termed α-synuclein(gT72). However, this general approach utilizing two recombinant fragments and one synthetic peptide is applicable to other sites and types of modifications and should be transferable to various other protein targets, including aggregation prone proteins like tau and TDP-43.

摘要

α-突触核蛋白是一种与帕金森病(PD)相关的小聚集倾向蛋白。该蛋白的生化和生物物理特性可能会受到各种类型的翻译后修饰(PTMs)的严重影响,如磷酸化、泛素化和糖基化。为了了解各种 PTM 对蛋白质及其聚集的特异性影响,获得具有感兴趣的特定修饰的感兴趣蛋白质的同质样品是关键。表达蛋白连接(EPL)已成为构建具有位点特异性修饰的合成蛋白的强大工具。在这里,我们概述了构建具有特定 O-GlcNAc 修饰的 α-突触核蛋白的方法,O-GlcNAc 修饰是一种与蛋白质聚集抑制有关的细胞内糖基化亚型。更具体地说,我们提供了在苏氨酸 72 位带有 O-GlcNAc 修饰的 α-突触核蛋白(α-synuclein(gT72))的合成方案。然而,这种利用两个重组片段和一个合成肽的通用方法适用于其他位点和类型的修饰,并且应该可以转移到各种其他蛋白质靶标,包括聚集倾向蛋白,如 tau 和 TDP-43。

相似文献

1
Investigating the Effects of O-GlcNAc Modifications in Parkinson's Disease Using Semisynthetic α-Synuclein.利用半合成α-突触核蛋白研究帕金森病中 O-GlcNAc 修饰的作用。
Methods Mol Biol. 2020;2133:313-326. doi: 10.1007/978-1-0716-0434-2_15.
2
O-GlcNAc modification inhibits the calpain-mediated cleavage of α-synuclein.O-连接的N-乙酰葡糖胺修饰可抑制钙蛋白酶介导的α-突触核蛋白的裂解。
Bioorg Med Chem. 2017 Sep 15;25(18):4977-4982. doi: 10.1016/j.bmc.2017.04.038. Epub 2017 Apr 29.
3
O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's disease.O-连接的N-乙酰葡糖胺修饰可阻止与帕金森病相关的蛋白质α-突触核蛋白的聚集和毒性。
Nat Chem. 2015 Nov;7(11):913-20. doi: 10.1038/nchem.2361. Epub 2015 Oct 12.
4
O-GlcNAcylation of truncated NAC segment alters peptide-dependent effects on α-synuclein aggregation.NAC 截断段的 O-GlcNAc 修饰改变了肽依赖性对 α-突触核蛋白聚集的影响。
Bioorg Chem. 2020 Jan;94:103389. doi: 10.1016/j.bioorg.2019.103389. Epub 2019 Nov 9.
5
O-GlcNAcylation of α-Synuclein at Serine 87 Reduces Aggregation without Affecting Membrane Binding.丝氨酸87位点的α-突触核蛋白O-连接N-乙酰葡糖胺化减少聚集而不影响膜结合。
ACS Chem Biol. 2017 Apr 21;12(4):1020-1027. doi: 10.1021/acschembio.7b00113. Epub 2017 Feb 22.
6
α-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson's disease.α-突触核蛋白的 O-连接糖基化改变了其聚集和毒性,揭示了某些残基可能是帕金森病的潜在抑制剂。
Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1511-1519. doi: 10.1073/pnas.1808845116. Epub 2019 Jan 16.
7
The Sulfur-Linked Analogue of O-GlcNAc (S-GlcNAc) Is an Enzymatically Stable and Reasonable Structural Surrogate for O-GlcNAc at the Peptide and Protein Levels.O-连接的N-乙酰葡糖胺(O-GlcNAc)的硫连接类似物(S-GlcNAc)在肽和蛋白质水平上是一种酶稳定且合理的O-GlcNAc结构替代物。
Biochemistry. 2017 Jul 11;56(27):3507-3517. doi: 10.1021/acs.biochem.7b00268. Epub 2017 Jun 30.
8
Exploring the Roles of Post-Translational Modifications in the Pathogenesis of Parkinson's Disease Using Synthetic and Semisynthetic Modified α-Synuclein.利用合成和半合成修饰的 α-突触核蛋白探索帕金森病发病机制中的翻译后修饰作用。
ACS Chem Neurosci. 2019 Feb 20;10(2):910-921. doi: 10.1021/acschemneuro.8b00447. Epub 2019 Jan 18.
9
O-GlcNAc modification prevents peptide-dependent acceleration of α-synuclein aggregation.O-GlcNAc 修饰可防止肽依赖性加速α-突触核蛋白聚集。
Chembiochem. 2012 Dec 21;13(18):2665-70. doi: 10.1002/cbic.201200478. Epub 2012 Nov 9.
10
Site-Specific Phosphorylation of PDZ Domains.PDZ 结构域的位点特异性磷酸化。
Methods Mol Biol. 2020;2133:235-261. doi: 10.1007/978-1-0716-0434-2_12.

引用本文的文献

1
A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson's disease.一种基于网络的系统遗传学框架识别帕金森病中的病理生物学和药物再利用。
Res Sq. 2024 Oct 14:rs.3.rs-4869009. doi: 10.21203/rs.3.rs-4869009/v1.
2
Protective effect of increased O-GlcNAc cycling against 6-OHDA induced Parkinson's disease pathology.O-GlcNAc循环增加对6-羟基多巴胺诱导的帕金森病病理的保护作用。
Cell Death Dis. 2024 Apr 23;15(4):287. doi: 10.1038/s41419-024-06670-1.
3
Phosphorylation and O-GlcNAcylation at the same α-synuclein site generate distinct fibril structures.

本文引用的文献

1
α-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson's disease.α-突触核蛋白的 O-连接糖基化改变了其聚集和毒性,揭示了某些残基可能是帕金森病的潜在抑制剂。
Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1511-1519. doi: 10.1073/pnas.1808845116. Epub 2019 Jan 16.
2
Simple and Efficient Preparation of O- and S-GlcNAcylated Amino Acids through InBr-Catalyzed Synthesis of β- N-Acetylglycosides from Commercially Available Reagents.通过 InBr 催化的商业可得试剂合成 β-N-乙酰糖苷,从简单和高效的制备 O- 和 S-GlcNAc 化氨基酸。
Org Lett. 2018 Aug 17;20(16):5032-5035. doi: 10.1021/acs.orglett.8b02182. Epub 2018 Aug 8.
3
磷酸化和 O-GlcNAc 化在同一个α-突触核蛋白位点产生不同的纤维结构。
Nat Commun. 2024 Mar 27;15(1):2677. doi: 10.1038/s41467-024-46898-1.
4
Top/Middle-Down Characterization of α-Synuclein Glycoforms.α-突触核蛋白糖型的从头至中分析。
Anal Chem. 2023 Dec 12;95(49):18039-18045. doi: 10.1021/acs.analchem.3c02405. Epub 2023 Dec 4.
5
-GlcNAc Modification and Its Role in Diabetic Retinopathy.N-乙酰葡糖胺修饰及其在糖尿病视网膜病变中的作用。
Metabolites. 2022 Aug 5;12(8):725. doi: 10.3390/metabo12080725.
A Chemoenzymatic Histology Method for O-GlcNAc Detection.
一种用于O-连接N-乙酰葡糖胺检测的化学酶组织学方法。
Chembiochem. 2017 Dec 14;18(24):2416-2421. doi: 10.1002/cbic.201700515. Epub 2017 Dec 5.
4
Enzymatic O-GlcNAcylation of α-synuclein reduces aggregation and increases SDS-resistant soluble oligomers.α-突触核蛋白的酶促O-连接N-乙酰葡糖胺化减少聚集并增加耐十二烷基硫酸钠的可溶性寡聚体。
Neurosci Lett. 2017 Aug 10;655:90-94. doi: 10.1016/j.neulet.2017.06.034. Epub 2017 Jul 1.
5
Quantitative proteomics identifies altered O-GlcNAcylation of structural, synaptic and memory-associated proteins in Alzheimer's disease.定量蛋白质组学鉴定出阿尔茨海默病中结构、突触和记忆相关蛋白的O-连接N-乙酰葡糖胺化改变。
J Pathol. 2017 Sep;243(1):78-88. doi: 10.1002/path.4929. Epub 2017 Jul 28.
6
Protein O-GlcNAcylation: emerging mechanisms and functions.蛋白质O-连接的N-乙酰葡糖胺糖基化:新出现的机制与功能
Nat Rev Mol Cell Biol. 2017 Jul;18(7):452-465. doi: 10.1038/nrm.2017.22. Epub 2017 May 10.
7
O-GlcNAcylation of α-Synuclein at Serine 87 Reduces Aggregation without Affecting Membrane Binding.丝氨酸87位点的α-突触核蛋白O-连接N-乙酰葡糖胺化减少聚集而不影响膜结合。
ACS Chem Biol. 2017 Apr 21;12(4):1020-1027. doi: 10.1021/acschembio.7b00113. Epub 2017 Feb 22.
8
Loss of O-GlcNAc glycosylation in forebrain excitatory neurons induces neurodegeneration.前脑兴奋性神经元中O-连接的N-乙酰葡糖胺糖基化缺失会诱发神经退行性变。
Proc Natl Acad Sci U S A. 2016 Dec 27;113(52):15120-15125. doi: 10.1073/pnas.1606899113. Epub 2016 Dec 12.
9
Versatile Structures of α-Synuclein.α-突触核蛋白的多样结构
Front Mol Neurosci. 2016 Jun 20;9:48. doi: 10.3389/fnmol.2016.00048. eCollection 2016.
10
O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's disease.O-连接的N-乙酰葡糖胺修饰可阻止与帕金森病相关的蛋白质α-突触核蛋白的聚集和毒性。
Nat Chem. 2015 Nov;7(11):913-20. doi: 10.1038/nchem.2361. Epub 2015 Oct 12.